Disease-related complications and management are different among patients with thalassemia. This study was aimed to review the prevalence, clinical risk factors for the complications and the management in patients with thalassemia in Thailand. A multicenter cross-sectional study was conducted in patients with thalassemia aged ≥ 18 years old. Thalassemia-related complications and management were reviewed. The clinical parameters significantly associated with the complications were analyzed by logistic regression methods. The prevalence of thalassemia-related complications was 100% in patients with transfusion-dependent thalassemia (TDT) and 58.8% in patients with non-transfusion-dependent thalassemia (NTDT). Advanced age was statistically as...
The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a c...
PubMedID: 30657116In adult thalassemia major (TM) patients, a number of occult and emerging endocrin...
Our understanding of the molecular and pathophysiological mechanisms underlying the disease process ...
Disease-related complications and management are different among patients with thalassemia. This stu...
Introduction: \u3b2-Thalassemia syndromes are among the most common monogenic disorders worldwide. C...
Abstract Based on Thalassemia International Federation clinical practice guidelines (CPG) for non-tr...
Despite recent advances in understanding the pathophysiologic mechanisms behind the thalassemia inte...
OBJECTIVES: Despite the correct application of blood transfusions and chelation treatments, beta ...
In this survey, we examined the associated complications and conditions of the patients suffering wi...
Abstract. Treatment of thalassemia major is complex, expensive and requires a multidisciplinary appr...
Copyright © 2015 Poramed Winichakoon et al. This is an open access article distributed under the Cre...
Thalassemia intermedia encompasses a wide clinical spectrum of beta-thalassemia phenotypes. Some tha...
Prevalence of the disease-related complications by age group in the 433 patients with thalassemia.</...
The clinical management of patients with thalassemia has changed in the last 40 years. Increasing kn...
Background: Thalassemia major patients require multiple blood transfusions in their life. The blood ...
The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a c...
PubMedID: 30657116In adult thalassemia major (TM) patients, a number of occult and emerging endocrin...
Our understanding of the molecular and pathophysiological mechanisms underlying the disease process ...
Disease-related complications and management are different among patients with thalassemia. This stu...
Introduction: \u3b2-Thalassemia syndromes are among the most common monogenic disorders worldwide. C...
Abstract Based on Thalassemia International Federation clinical practice guidelines (CPG) for non-tr...
Despite recent advances in understanding the pathophysiologic mechanisms behind the thalassemia inte...
OBJECTIVES: Despite the correct application of blood transfusions and chelation treatments, beta ...
In this survey, we examined the associated complications and conditions of the patients suffering wi...
Abstract. Treatment of thalassemia major is complex, expensive and requires a multidisciplinary appr...
Copyright © 2015 Poramed Winichakoon et al. This is an open access article distributed under the Cre...
Thalassemia intermedia encompasses a wide clinical spectrum of beta-thalassemia phenotypes. Some tha...
Prevalence of the disease-related complications by age group in the 433 patients with thalassemia.</...
The clinical management of patients with thalassemia has changed in the last 40 years. Increasing kn...
Background: Thalassemia major patients require multiple blood transfusions in their life. The blood ...
The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a c...
PubMedID: 30657116In adult thalassemia major (TM) patients, a number of occult and emerging endocrin...
Our understanding of the molecular and pathophysiological mechanisms underlying the disease process ...